期刊
NANOMEDICINE
卷 6, 期 9, 页码 1605-1620出版社
FUTURE MEDICINE LTD
DOI: 10.2217/NNM.11.141
关键词
apoptosis; extracellular matrix; interstitial fluid pressure; nanomedicine; nanotechnology; paclitaxel; RNAi; tumor-penetrating microparticles; tumor priming; vasculature normalization
资金
- National Cancer Institute [R43CA134047, R43CA121744, R44CA103133, R01CA123159, R01CA158300, R01EB015253]
- National Institute of General Medical Sciences, DHHS
Effectiveness of nanomedicines in cancer therapy is limited in part by inadequate delivery and transport in tumor interstitium. This article reviews the experimental approaches to improve nanomedicine delivery and transport in solid tumors. These approaches include tumor vasculature normalization, interstitial fluid pressure modulation, enzymatic extracellular matrix degradation, and apoptosis-inducing tumor priming technology. We advocate the latter approach due to its ease and practicality (accomplished with standard-of- care chemotherapy, such as paclitaxel) and tumor selectivity. Examples of applying tumor priming to deliver nanomedicines and to design drug/RNAi-loaded carriers are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据